Cyclophosphamide associated bladder cancer - A highly aggressive disease: Analysis of 12 cases

Journal of Urology

Volumn 156, Issue 6, 1996, Pages 1931-1933

  Fernandes, Eduardo T ^a   Manivel, J Carlos ^a   Reddy, Pratap K ^a   Ercole, Cesar J ^a  

^a NONE

Author keywords

bladder neoplasms; carcinoma; cyclophosphamide

Indexed keywords

ACROLEIN; CYCLOPHOSPHAMIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTECTOMY; ENDOSCOPIC SURGERY; FEMALE; HEMATURIA; HUMAN; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; UROTHELIUM;

EID: 0029973620     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65395-3     Document Type: Article

References (20)

1. Levine, L. A. and Richie, J. P.: Urological complications of cyclophosphamide. J. Urol., 141: 1063, 1989.
2. Worth, P. H. L.: Cyclophosphamide and the bladder. Brit. Med. J., 3: 182, 1971.
3. Fairchild, W. V., Spence, C. R., Solomon, H. D. and Gangai, M. P.: The incidence of bladder cancer after cyclophosphamide therapy. J. Urol., 122: 163, 1979.
4. Wall, R. L. and Clausen, K. P.: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. Letter to the Editor. New Engl. J. Med., 293: 271, 1975.
5. Thrasher, J. B., Miller, G. J. and Wettlaufer, J. N.: Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J. Urol., 143: 119, 1990.
6. Chodak, G. W., Straus, F. W., II and Schoenberg, H. W.: Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion. J. Urol., 125: 424, 1981.
7. Pedersen-Bjergaard, J., Ersbøll, J., Hansen, V. L., Sørensen, B. L., Christoffersen, K., Hou-Jensen, K., Nissen, N. I., Knudsen, J. B. and Hansen, M. M.: Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. New Engl. J. Med., 318: 1028, 1988.
8. Cannon, J., Linke, C. A. and Cos, L. R.: Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention. Urology, 38: 413, 1991.
9. Plotz, P. H., Klippel, J. H., Decker, J. L., Grauman, D., Wolff, B., Brown, B. C. and Rutt, G.: Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann. Intern. Med., 91: 221, 1979.
10. Fuchs, E. F., Kay, R., Poole, R., Barry, J. M. and Pearse, H. D.: Uroepithelial carcinoma in association with cyclophosphamide ingestion. J. Urol., 126: 544, 1981.
11. Durkee, C. and Benson, R., Jr.: Bladder cancer following administration of cyclophosphamide. Urology, 16: 145, 1980.
12. Tuttle, T. M., Williams, G. M. and Marshall, F. F.: Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient. J. Urol., 140: 1009, 1988.
13. Ortiz, A., Gonzalez-Parra, E., Alvarez-Costa, G. and Egido, J.: Bladder cancer after cyclophosphamide therapy for lupus nephritis. Letter to the Editor. Nephron, 60: 378, 1992.
14. Garvin, D. D. and Ball, T. P., Jr.: Bladder malignancy in patient receiving cyclophosphamide for benign disease. Urology, 18: 80, 1981.
15. Albanell, J., Gallego, O. S., Bellmunt, J., Vicente, P., Morales, S. and Sole, L. A.: Neoplasia de vejiga en un paciente afecto de panarteritis nodosa tratado con ciclofosfamida. Rev. Clin. Esp., 190: 463, 1992.
16. Freedman, A., Ehrlich, R. M. and Ljung, B-M: Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study. J. Urol., 132: 580, 1984.
17. Habs, M. R. and Schmähl, D.: Prevention of urinary bladder tumors in cyclophosphamide-treated rates by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2-dithio-bis-ethane sulfonate (dimesna). Cancer, 51: 606, 1983.
18. Hows, J., Mehta, A. and Gordon-Smith, E. C.: Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data). Cancer Treat. Rev., suppl. A, 10: 53, 1983.
19. Shulman, L. N.: The biology of alkylating-agent cellular injury. Hematol. Oncol. Clin. N. Amer., 7: 325, 1993.
20. Ansell, I. D. and Castro, J. E.: Carcinoma of the bladder complicating cyclophosphamide therapy. Brit. J. Urol., 47:413, 1975.